The activation antigen BLAST-2, when shed, is an autocrine BCGF for normal and transformed B cells - PubMed (original) (raw)

The activation antigen BLAST-2, when shed, is an autocrine BCGF for normal and transformed B cells

S Swendeman et al. EMBO J. 1987 Jun.

Abstract

A shed form of the membrane-bound B cell activation marker, BLAST-2 (Epstein-Barr virus cell surface, CD 23) was immune-affinity purified from Epstein-Barr virus-transformed lymphoblast conditioned medium. SDS-PAGE analysis revealed a complex of two polypeptides, mol. wts 25,000 and 12,000, here termed s-BLAST-2. We show that this complex, when purified to homogeneity, can act as a growth factor for EBV-infected B lymphoblasts and normal receptor-stimulated B cell blasts. It has no effect on resting B or T cells. These data suggest that the BLAST-2 antigen has a role in autocrine B cell growth. Additionally, this complex is a co-mitogen for PHA-stimulated murine thymocytes, a property of interleukin-1.

PubMed Disclaimer

Similar articles

• B cell growth and differentiation factors.
  Brooks K, Fernandez R, Vitetta ES. Brooks K, et al. Methods Enzymol. 1985;116:372-9. doi: 10.1016/s0076-6879(85)16029-5. Methods Enzymol. 1985. PMID: 3937026 No abstract available.
• BLAST-2 [EBVCS], an early cell surface marker of human B cell activation, is superinduced by Epstein Barr virus.
  Thorley-Lawson DA, Nadler LM, Bhan AK, Schooley RT. Thorley-Lawson DA, et al. J Immunol. 1985 May;134(5):3007-12. J Immunol. 1985. PMID: 2984280
• Activation and immunoregulation of human B lymphocytes.
  Kehrl JH, Muraguchi A, Falkoff RJ, Ambrus JL Jr, Butler JL, Fauci AS. Kehrl JH, et al. Uremia Invest. 1984-1985;8(3-4):157-66. doi: 10.3109/08860228409115838. Uremia Invest. 1984. PMID: 6085841
• Regulation of B cell activation and differentiation with factors generated by human T cell hybridomas.
  Mayer L, Fu SM, Kunkel HG. Mayer L, et al. Immunol Rev. 1984 Apr;78:119-35. doi: 10.1111/j.1600-065x.1984.tb00479.x. Immunol Rev. 1984. PMID: 6234220 Review.
• B cell growth and differentiation factors and mechanism of B cell activation.
  Kishimoto T, Yoshizaki K, Kimoto M, Okada M, Kuritani T, Kikutani H, Shimizu K, Nakagawa T, Nakagawa N, Miki Y, et al. Kishimoto T, et al. Immunol Rev. 1984 Apr;78:97-118. doi: 10.1111/j.1600-065x.1984.tb00478.x. Immunol Rev. 1984. PMID: 6234224 Review. No abstract available.

Cited by

• Dynamic changes of territories 17 and 18 during EBV-infection of human lymphocytes.
  Li C, Shi Z, Zhang L, Huang Y, Liu A, Jin Y, Yu Y, Bai J, Chen D, Gendron C, Liu X, Fu S. Li C, et al. Mol Biol Rep. 2010 Jun;37(5):2347-54. doi: 10.1007/s11033-009-9740-y. Epub 2009 Aug 15. Mol Biol Rep. 2010. PMID: 19685159
• Anti-CD23.
  Rosenwasser LJ, Meng J. Rosenwasser LJ, et al. Clin Rev Allergy Immunol. 2005 Aug;29(1):61-72. doi: 10.1385/CRIAI:29:1:061. Clin Rev Allergy Immunol. 2005. PMID: 16222084 Review.
• Dendritic cells initiate immune control of epstein-barr virus transformation of B lymphocytes in vitro.
  Bickham K, Goodman K, Paludan C, Nikiforow S, Tsang ML, Steinman RM, Münz C. Bickham K, et al. J Exp Med. 2003 Dec 1;198(11):1653-63. doi: 10.1084/jem.20030646. J Exp Med. 2003. PMID: 14657218 Free PMC article.
• Promoter-specific targeting of human SWI-SNF complex by Epstein-Barr virus nuclear protein 2.
  Wu DY, Krumm A, Schubach WH. Wu DY, et al. J Virol. 2000 Oct;74(19):8893-903. doi: 10.1128/jvi.74.19.8893-8903.2000. J Virol. 2000. PMID: 10982332 Free PMC article.
• Surface expression and release of soluble forms of CD8 and CD23 in CD40- and IL-4-activated mononuclear cells from patients with Graves' disease (GD).
  Itoh M, Uchimura K, Hayakawa N, Makino M, Hayashi R, Nagata M, Kakizawa H, Nagasaka A, Sakamoto H, Kuzuya H. Itoh M, et al. Clin Exp Immunol. 1998 Aug;113(2):309-14. doi: 10.1046/j.1365-2249.1998.00658.x. Clin Exp Immunol. 1998. PMID: 9717983 Free PMC article.

References

1. 1. Cancer Res. 1978 Nov;38(11 Pt 2):4147-54 - PubMed
2. 1. Eur J Immunol. 1986 Sep;16(9):1075-80 - PubMed
3. 1. J Immunol. 1981 Mar;126(3):1075-9 - PubMed
4. 1. J Immunol. 1982 Sep;129(3):1104-8 - PubMed
5. 1. Cell. 1982 Sep;30(2):415-25 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • Nature Publishing Group
  • PubMed Central
  • Wiley

• Other Literature Sources

  • The Lens - Patent Citations

• Research Materials

  • NCI CPTC Antibody Characterization Program